Prosecution Insights
Last updated: April 19, 2026
Application No. 17/328,985

ENDOVASCULAR DELIVERY SYSTEM WITH AN IMPROVED RADIOPAQUE MARKER SCHEME

Non-Final OA §102§103
Filed
May 24, 2021
Examiner
HOLWERDA, KATHLEEN SONNETT
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
TriVascular, Inc.
OA Round
7 (Non-Final)
69%
Grant Probability
Favorable
7-8
OA Rounds
3y 9m
To Grant
85%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
652 granted / 949 resolved
-1.3% vs TC avg
Strong +17% interview lift
Without
With
+16.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
55 currently pending
Career history
1004
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
43.5%
+3.5% vs TC avg
§102
25.5%
-14.5% vs TC avg
§112
21.2%
-18.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 949 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application is being examined under the pre-AIA first to invent provisions. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 2/3/2026 has been entered. Response to Arguments The amendments have overcome the previously presented claim objections and 35 USC 112b rejections. Applicant's arguments filed 2/3/2026 with respect to the prior art of Krivoruchko have been fully considered but they are not persuasive. Applicant asserts that the amendments to claims 1, 16 and 17 distinguish the claimed invention from the prior art of Krivoruchko. The examiner respectfully disagrees. Krivoruchko discloses a rotatable prosthesis holder comprising a body (44) and a plurality of radiopaque markers (46) (see figs. 1-3). The body of the first and second radiopaque markers (44) are disposed on an outer surface of the inner tubular member (24) because the rotatable prosthesis holder (44) is claimed as part of the inner tubular member (“said inner tubular member comprising a body, a lumen, a longitudinal axis and a proximal portion comprising: a rotatable prosthesis holder comprising a body….”). Additionally, though not currently required by the claims, the radiopaque markers are considered disposed on an outer surface of the body (tube 24) of the inner tubular member, by way of the rotatable prosthesis holder, which contacts an outer surface of the body of the inner tubular member. With respect to claim 7, Applicant’s argument with respect to the combination of Krivoruchko in view of Tanabe is not found persuasive. Applicant asserts that “it is extremely challenging to envisage how a coating would be applied on the surface such that it would have a longitudinal axis in a direction generally perpendicular to the inner tubular member longitudinal axis”, but provides no evidence to support this assertion. The marker taught by Tanabe is provided as a ring having a diameter (“D”; fig. 5) that is larger than the axial length (“L”; fig. 5) of the ring. Thus, the longitudinal axis of the marker extends in the diameter direction of the ring as this is the longer dimension. The longitudinal axis of the ring (i.e., the axis in the diameter direction) is perpendicular to the longitudinal axis of the tubular member upon which the marker is disposed. It is unclear why such a ring shape could be applied to the surface of the body (44) of the prothesis holder of Krivoruchko, and thus the rejection is maintained. The amendment to claim 19 requiring a second marker having a longitudinal axis aligned in a direction generally perpendicular to the inner tubular member has overcome the previously presented 35 USC 102 rejection of claims 19 and 20 over Krivoruchko. However, claims 19 and 20 are now rejected under 35 USC 103 over Krivoruchko in view of Tanabe as discussed below. The amendments to claim 5 have overcome the previous rejection. However, claim 5 is now rejected over Krivoruchko in further view of Vrba et al. (US 2002/0072705). Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of pre-AIA 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (b) the invention was patented or described in a printed publication in this or a foreign country or in public use or on sale in this country, more than one year prior to the date of application for patent in the United States. Claim(s) 1-4, 6, 8-12, 14-18, and 21 is/are rejected under pre-AIA 35 U.S.C. 102b as being anticipated by Krivoruchko (US 2008/0243069). Regarding claims 1 and 16, Krivoruchko discloses an endovascular delivery system comprising an elongate outer tubular device (20) having an open lumen and opposed proximal and distal end with a medial portion therein between, an inner tubular member (24) configured to be disposed within the outer tubular device (fig. 1), the inner tubular member comprising a body (24), a lumen (25), a longitudinal axis and a proximal portion comprising a rotatable prosthesis holder (noting entire device can be rotated) comprising a body (44) and a plurality of radiopaque markers (46), and an outer surface (e.g., outer surface of balloon 18 or outer surface of body 24) upon which a prosthesis may be secured prior to delivery (noting prosthesis is not positively recited; a stent can be mounted onto the outer surface of the balloon and thus the prior art of Krivorcuchko meets this recitation of intended use; it is also noted that the stent can be considered secured upon an outer surface of the body 24 of the inner tubular member by way of the balloon). The plurality of radiopaque markers comprises a first marker (one platinum strip 46; fig. 2) having a body and a longitudinal axis aligned in a direction generally parallel to the inner tubular member longitudinal axis and a second marker (another one of the platinum strips 46; fig. 2) having a body and a longitudinal axis aligned in a direction generally parallel to the inner tubular member longitudinal axis. The body of the first or second radiopaque marker is a distinct elongate structure disposed on an outer surface of the inner tubular member (i.e., outer surface of rotatable prosthesis holder body 44, which is claimed as part of the inner tubular member; it is noted that the outer surface of line 9 of claim 1 and the outer surface of line 15 of claim 1 need not be the same). The body of the first and second radiopaque marker comprises a first material (platinum; [0026]), and the body of the inner tubular member comprises a second material (radiolucent material according to par. [0024]). PNG media_image1.png 255 508 media_image1.png Greyscale Regarding claim 2, see element (26) in fig. 1, which one skilled in the art would understand to be an axial guidewire. Regarding claims 3 and 20, the first and second radiopaque marker longitudinal axes are radially offset from the inner tubular member longitudinal axis (figs. 1-3). Regarding claim 4, Krivoruchko further discloses a third marker having a longitudinal axis aligned in a direction generally parallel to the inner tubular member longitudinal axis, the third marker disposed at an approximately 90-degree interval from the first maker as measured from the inner tubular as measured from the inner tubular member longitudinal axis (figs. 1-3; see examiner-annotated figure below). PNG media_image2.png 330 508 media_image2.png Greyscale Regarding claims 6 and 16, the bodies of the first and second markers 46 do not envelop the inner tubular member longitudinal axis (figs. 1-3). Regarding claim 8, the second material (material of 24) of the body of the inner tubular member does not enclose the first material of the first or second radiopaque marker (see fig. 3). Regarding claim 9, the first and/or second marker is made of platinum ([0026]). Regarding claim 10, the first and second markers are disposed at an approximately 180 degree interval from each other as measured from the inner tubular member longitudinal axis (See annotated fig. 3 above). Regarding claim 11, as noted above, the first and/or second marker is made of platinum and thus meets the limitations of claims 9 and 11, noting claim 11 does not require that the first and second markers are made of radiopaque polymeric materials. Rather, claim 11 further defines the radiopaque materials. Regarding claim 12, the body of the rotatable prothesis holder is not radiopaque (radiolucent material according to par. [0024]). Regarding claim 14, the first and second markers each comprise a solid construction as understood in view of figs. 1-3. It is noted that any construction would appear to fall within the group “consisting of a hollow construction, a partially hollow construction and a solid construction”. Regarding claim 15, the limitation “wherein a first interior portion of the body of the prosthesis holder is different from a second interior portion of the body of the prosthesis holder” is extremely broad in that the portions may be any size and the claim does not specify a particular property which must be different. Since a first interior portion of the body can be chosen that is twice as big as a second interior portion of the body and therefore different in size from the second interior portion of the body, the prior art of Krivoruchko meets this limitation. Even if two portions of equal size are chosen, as long as they occupy different space, they can be considered different. Regarding claim 18, the first marker (46) has a longitudinal axis radially displaced from the axial guidewire (26) longitudinal axis (figs. 1-3). Regarding claim 21, the second material (material forming tube 24) of the body (24) of the inner tubular member does not enclose the first material of the first or second radiopaque markers (See figs. 1-3). Regarding claim 17, see the discussion of claim 1 above. Krivoruchko discloses that the first and second markers may be spaced at an approximately 90-degree interval as measured around a longitudinal axis formed by the axial guidewire (26). See the examiner-annotated figure below, on which the first and second markers are labelled (for claim 17). PNG media_image3.png 306 335 media_image3.png Greyscale Claim Rejections - 35 USC § 103 The following is a quotation of pre-AIA 35 U.S.C. 103(a) which forms the basis for all obviousness rejections set forth in this Office action: (a) A patent may not be obtained though the invention is not identically disclosed or described as set forth in section 102, if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 7, 19, and 20 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Krivoruchko in view of Tanabe (US 4,838,879). Regarding claims 7 and 19, Krivoruchko discloses the invention substantially as stated above (regarding claim 19, see discussion of claim 1 above, noting first marker 44 does not envelop the inner tubular member longitudinal axis; see figs. 1-3) except for a marker (claimed “second marker” in claim 19) having a body and a longitudinal axis aligned in a direction generally perpendicular to the inner tubular member longitudinal axis. Tanabe discloses another catheter having a longitudinal axis, wherein the catheter has at least one radiopaque marker (3) provided on the catheter for indicating the direction of the end portion, the radiopaque marker having a longitudinal axis aligned in a direction generally perpendicular to the inner tubular member longitudinal axis (col. 3, ll. 13-27; col. 4, ll. 17-21). According to Tanabe, the orientation of the radiopaque marker allows the direction of the distal end of the catheter to be easily identified. It would have been obvious to one of ordinary skill in the art to have modified the prior art of Krivoruchko to include an additional radiopaque marker (considered claimed “second marker” in claim 19), the marker having a longitudinal axis aligned in a direction generally perpendicular to the inner tubular member longitudinal axis in view of the teachings of Tanabe in order to allow the direction of the distal end of the catheter to be easily identified to facilitate insertion into the location of interest. Regarding claim 20, as discussed above with respect to claim 1, the longitudinal axis of the first marker (44; fig. 1-2 of Krivoruchko) is radially offset from the inner tubular member longitudinal axis (which passes through center of rotatable prosthesis holder body 44). Claim 5 is/are rejected under pre-AIA 35 U.S.C. 103(a) as being unpatentable over Krivoruchko in view of Vrba et al. (US 2002/0072705). Krivoruchko disclose the invention substantially including a rotatable prosthesis holder comprising a body (44; fig. 1, 3) and a plurality of radiopaque markers (46), but fails to disclose that the body of the first or second radiopaque markers is disposed between the lumen (25) of the inner tubular member (24) and the body (44) of the rotatable prosthesis holder, and instead discloses the markers on an outer surface of the body (see figs. 1, 3). Vrba discloses another catheter that includes radiopaque marker. Vrba discloses, as an alternative to a marker (98; fig. 8A,8B and [0060]) attached to the external surface of a tubular member (76), a marker (94; fig. 6a,6b) completely embedded in the wall of the tubular member (76). It would have been obvious to one of ordinary skill in the art to have modified the prior art of Krivoruchko to completely embed the radiopaque markers (46) within the wall of the body (44) of the rotatable prosthesis in view of Vrba’s disclosure that a radiopaque marker completely embedded within the wall of a tubular member is a known alternative to a radiopaque marker attached to an outer surface of the wall of a tubular member, and such a modification can be consider a simple substitution of one known radiopaque placement for another wherein the results are predictable and one skilled in the art would have had a reasonable expectation of success. With such a modification, the radiopaque markers are disposed between the lumen (25) of the inner tubular member of Krivoruchko and an outermost surface of the body (44) of the rotatable prosthesis holder since the markers are completely embedded within the material of the body (44) of the rotatable prosthesis holder as made obvious by Vrba (figs. 6a, 6b). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHLEEN SONNETT HOLWERDA whose telephone number is (571)272-5576. The examiner can normally be reached M-F, 8-5, with alternate Fridays off. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached on 571-272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. KSH 3/13/2026 /KATHLEEN S HOLWERDA/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

May 24, 2021
Application Filed
Dec 02, 2022
Non-Final Rejection — §102, §103
Jun 07, 2023
Response Filed
Jul 11, 2023
Final Rejection — §102, §103
Oct 17, 2023
Applicant Interview (Telephonic)
Oct 17, 2023
Examiner Interview Summary
Jan 03, 2024
Request for Continued Examination
Jan 09, 2024
Response after Non-Final Action
Feb 15, 2024
Non-Final Rejection — §102, §103
Aug 21, 2024
Response Filed
Oct 04, 2024
Final Rejection — §102, §103
Mar 03, 2025
Applicant Interview (Telephonic)
Mar 05, 2025
Examiner Interview Summary
Mar 06, 2025
Request for Continued Examination
Mar 07, 2025
Response after Non-Final Action
Apr 04, 2025
Non-Final Rejection — §102, §103
Oct 08, 2025
Response Filed
Oct 31, 2025
Final Rejection — §102, §103
Feb 03, 2026
Request for Continued Examination
Feb 25, 2026
Response after Non-Final Action
Mar 13, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594096
SYSTEMS AND METHODS FOR ENHANCED IMPLANTATION OF ELECTRODE LEADS BETWEEN TISSUE LAYERS
2y 5m to grant Granted Apr 07, 2026
Patent 12588908
Independent Gripper
2y 5m to grant Granted Mar 31, 2026
Patent 12582431
SURGICAL INSTRUMENT WITH SELECTOR
2y 5m to grant Granted Mar 24, 2026
Patent 12564459
ACTIVE DRIVES FOR ROBOTIC CATHETER MANIPULATORS
2y 5m to grant Granted Mar 03, 2026
Patent 12551657
CUSTOM LENGTH STYLET
2y 5m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
69%
Grant Probability
85%
With Interview (+16.7%)
3y 9m
Median Time to Grant
High
PTA Risk
Based on 949 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month